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The effects of carbogen and nicotinamide on intravascular
oxyhaemoglobin saturations in SCCVII and KHT murine tumours
BM Fenton
Department ofRadiation Oncology, University ofRochester Medical Center, Rochester, New York 14642, USA.
Sary Consierable effort has been focused on devising methods for pulating tumour oxygenation
and thereby improing tumour radiosensitivity. The combination of nicotnamid and arbogen has been
proposed to oxygenate both chronicaly and acutely hypoxic cells in tumours. However, results have varied
markedly with both tumour model and measurement technique. The current objectives were (1) to determine
whether chang in radiosensitivity following oxygen manipulation correlated with changes in tumour
oxygenation and (2) to asess whether oxygenauion was preferentially improved in specific tumour micro-
regions. Usng two murne tumour lnes, the SCCVII carcinoma and the KHT sarcoma, tumour intravascular
HbO2 saturations were measured cryospectrophotometrically following nicotinamide, carbogen or the com-
bination- Generally, nicotinamide had minor effects on oxygenation, arguing against a substantial effect on
acute hypoxia, while carbogen and the combination produced marked and equivalent improvements in oxygen
availability. These results demonstrate that changes in tumour radiosensitivity may not agree with correspond-
ing changes in oxygenatoKn, even within a given tumour model, and that the efficacy of a given manipulative
agent may vary substantially with tumour line. One possible explanation for these findings is that different
subpopulations of cogenwic vs non-donogenic cells may be oxygenated by alternative treatments.
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Over the past few decades, numerous clinical and experiment-
al studies have attempted to improve tumour radioresponse
through the enhancement of tumour oxygenation. Several
recent reports have indicated that either carbogen breathing
(95% oxygen, 5% carbon dioxide) or nicotinamide (NIC)
administration, alone or in combination, can effectively
radiosensitise tumours in mice (Rojas, 1991; Chaplin et al.,
1993; Simon et al., 1993; Siemann et al., 1994; Done et al.,
1994; Martin et al., 1994). It is generally believed that car-
bogen breathing improves response by increasing the amount
of oxygen physically dissolved in the blood, thereby increas-
ing the distance the oxygen is able to diffuse from the blood
vessels to the tumour cells, and possibly by increasing
tumour blood flow (Kruuv et al., 1967). NIC, on the other
hand, has been suggested to increase tumour oxygenation by
reducing temporal fluctuations in tumour blood flow (Chap-
lin et al., 1990, 1991; Horsman et al., 1990) in addition to
increasing tumour blood flow (Horsman et al., 1989; Stone et
al., 1992; Kelleher and Vaupel, 1993).
Although previous studies have generally shown the great-
est enhancement of radiosensitivity following the combina-
tion of NIC and carbogen, results are highly variable among
different tumour models and laboratories. For example, in
the CaNT mouse mammary carcinoma (Kjellen et al., 1991),
NIC demonstrated no significant effect, while carbogen and
the combination showed equivalent enhancements. In the
KHT sarcoma, the treatments had similar effects when
delivered under optimum conditions (Siemann et al., 1994).
Finally, in the SCCVII carcinoma, carbogen and NIC were
equivalent, while the combination was superior (Chaplin et
al., 1993). Measurements of alterations in tumour oxygena-
tion following these agents have also varied markedly with
tumour line (Lee and Song, 1992; Fenton and Boyce, 1993;
Kelleher and Vaupel, 1993; Horsman et al., 1995; Martin et
al., 1994).
A key question is whether a relationship exists between
direct measures of tumour oxygenation and corresponding
determinations of tumour radiosensitivity. Since tumour
radiosensitivity is commonly calculated from the ratio of the
fraction of anoxic clonogenic tumour cells to the fraction of
total clonogenic cells (Moulder and Rockwell, 1984), it fol-
lows that if substantially different proportions of clonogenic
and non-clonogenic tumour cells are oxygenated by the alter-
native treatments, direct measures of tumour oxygenation
will not correlate with changes in radiosensitivity (Fenton et
al., 1995). Thus, although clear relationships may be demon-
strated within specific tumour lines (Rofstad et al., 1988;
Horsman et al., 1993), attempts to define smilar correlations
across tumour lines have proven unsuccessful (Rofstad et al.,
1988; Horsman et al., 1995; Martin et al., 1994).
The objective ofthe current study was to define further the
physiological mechanisms responsible for the inter-tumour
differences in response to these two agents. Using two murine
tumour lines, the SCCVII carcinoma and the KHT sarcoma,
changes in tumour intravascular oxyhaemoglobin (HbO2)
profiles were quantified following NIC, carbogen or the com-
bination. The primary aim were (1) to determine whether
previously reported changes in radiosensitivity, following
growth and oxygen manipulation, could be explained solely
on the basis of changes in oxygen availability and (2) to
assess whether oxygen availability within specific regions of
the tumour, i.e. interior vs periphery, is preferentially im-
proved following the different treatments.
The major advantage of using tumour intravascular HbO2
saturations as an index of tumour oxygenation is that micro-
regional heterogeneities in oxygen availability can be spatially
defined with an unequalled precision. While these measure-
ments are not as direct a gauge of tumour radiosensitivity as
electrode measurements of local oxygen pressures (P02), they
may better reflect localised changes in tumour blood flow as
well as the ability of manipulative agents to eliminate local-
ised regions of anoxia. Neither anaesthesia nor physical re-
straint of the animals is required for these measurements.
Materal and metbod
Mice and tumour models
The KHT tumour (Kallman et al., 1967), a sarcoma main-
tained in vivo, and the SCCVII tumour, a squamous cell
carcnoma maintained by alternate in vivo/in vitro passage
(Olive et al., 1985), were used in all experiments. Using 6- to
8-week-old female C3H/HeJ mice (Jackson Laboratories, Bar
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Harbor, ME, USA), 2 x 101 KHT cells were inoculated intra-
muscularly into the hind limb or subcutaneously into the
flankr. For the SCCVII tumours, 2 x 10' cells were inoculated
intramuscularby into the hind limb. Tumours were selected
for cyrospectrophotometric analysis when they reached a
vohlme of between 180 and 900mm3.
Drugs
Nicotinamide (Sigma, St Louis, MO, USA) was freshly pre-
pared before each experiment in sterile phosphate-buffered
salne and injected intraperitonally at 1000mgkg-' I hr
before tumour freezing.
Carbogen breathing
Mice were confined to plastic jigs (S50cm3 vohlme) and
exposed to carbogen at a flow rate of -41min' for 7min
before tumour freezing.
Twnowfreezing andcryospectrophotometric determination of
HbO2 saturations
Approximately 2-3 h before freezing, tumours were first
shaved and a depilatory agent applied to accelerate tumour
freezing. Following each treatment, the mice we cervically
dislocated and the tumours im iately quick frozen using a
lquid nitrogen-cooled copper block and stored in cryotanks.
Tumour sectioning and samplig procedures were as pre-
viously described (Fenton and Boyce, 1993). Four cross-
sections of the tumour were exposed using a cooled scaWpel
blade in a dry ice-ethanol bath at -73-C. For HbO2 deter-
minations, the exposed tumour surfaces were analysed on a
liquid nitrogen-cooled microscope stage. Approximately 95
blood vessels (diameter > 6jam) were systematically seected
per tumour, the spatial positions of the blood vessels were
recorded using stage micrometers and intravascular HbO2
saturations were determined cryospecophotomerically as
previously described (Fenton and Gayeski, 1990). Briefly,
HbO2 saturations were cahlbrated as a function of re
light intensity at three discrete wavelengths, bawsed on the
spetral differences between oxy- and deoxyaemoglobin.
Since optcal density also vares as a function ofha obn
concentration and light pathlegth, the intensities at the three
wavelegths were combined to normalise the mesurement
and to cancel out these dependencies, thusallowing vels of
widely varying haematocrit to be analysed using a single
calibration curve.
Statistical considerations
The percentage of vessels containing > 25% HbO2 was cal-
culated for each of the tumours of a given treatment group,
and the means at each distance cl were compared usg
the unpaired Student f-test. Diffarnces were considered
signilicant for P<0.05.
Resis
Tumour intravascular HbO2 saturations vary as a function of
both tumour sze and spatial location within the tumour
volume. In the figures to follow, results are prsented in
terms of the percentage of vessels > 25% HbOQ saturation.
Although this is a somewhat arbitrary HbO2 cut-off, this
type of index is expected to correlate more closely with
corresponding changes in the radiobiological hypoxic fraction
than mean or median HbOlklvds, as has been disc in a
previous theoretical study (Fenton et al., 1995).
Figure I illustrates the percentage of vessels with - 25%
HbQ% saturation as a function ofdistanc of the vessels from
the tumour surface for small (mean = 315mm3) and medium
(mean = 733mm3) volume KHT tumours. e percntage
with > 25% HbO2 was signifiatly lower for the medium
tumours than for the small tumours for the first two disanc
classes (P= 0.002 and P= <0.001). At distanc of greater
than 2 mm from the tumour surface, however, the percentage
with > 25% HbO2 was not sigintly different between
small and medium tumours. Figure 2 compares percntage
with > 25% HbO2 for KHT tumours implanted into two
different sites. Tumour oxygen availabilty was signiicantly
lower for the subcutaneous implantation site in the flani in
relation to the intramuscular site in the hind leg at three of
the four distance dasses (P=0.002, 0.007, 0.122 and
0.039).
Changes in the percntage with > 25% HbO2 following
NIC inistration, carbogen breathing or the combination
treatment compared with the untreated volume-matched
KHT controls are summarised in Figure 3. The values
obtained in NIC-treated animals were sinifintly different
from those in untreated controls at only one of the four
distance casses (P=0.962, 0.018, 0.067 and 0.729). For car-
bogen breathing, the prentage with > 25% HbO2 was
sigcantly higher than untreated at each of the first three
distanc casses (P=0.003, 0.006, 0.003 and 0.299). For the
combination treatment, the percntage with . 25% HbO2
was siiantly higher at all disances (P=0.005, 0.0003,
0.0005 and 0.022). Fmally, the combination treatment was
signifntly higher than the NIC at two of the distancs
(P=0.023, 0.163, 0.093 and 0.010) while not significntly
different from the carbogen-breathing treatment at any dis-
tance.
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Fugwe I Percentage of vessels with ) 25% HbO2 (mean ±
se.m.) as a function ofditance from the tumour surfm. SmaIl-
volume KHT umous (U, 315±46mm3, n=6) are contasted
with medium volume tumours (V, 733 ± 42mm3, n = 6).
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Flge 2 Percentage of ve}s with > 25% HbO2 (mean ±
sxemn) as a functio of distanc from the tumour surface. Intra-
muscular KHT tumour im ntations (V, 529± 58 n , n = 8)
are contasted with subutanous impantation (0, 591 ± 40
mm3, = 7).
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ICorresponding results for the SCCVII tumours are shown
m Figure 4. For the SCCVII tumours, NIC produced a
significant increase in percentage with >s 25% HbO2 only at
the most peripheral distance class (P = 0.019). For carbogen
breathing, the percentage with > 25% HbO2 was again
significantly increased for each of the first three distance
classes (P = 0.0001, 0.0004, 0.0042 and 0.264). For the com-
bination treatment, percentage with ) 25% HbO2 was
significantly higher only for the first two distance classes
(P =0.003, 0.013, 0.060 and 0.842). As with the KHT, no
significant differences were found between the carbogen
breathing and the combination treatment. In contrast to the
KHT, however, no significant differences were observed
between the NIC and the combination treatment for the
SCCVII tumours.
To illustrate more clearly overall variations between the
two tumour lines, Figure 5 presents the mean percentage with
> 25% HbO2 averaged over the four distance classes. Over-
all the percentage of vessels with > 25% HbO2 was calcul-
ated by taking the mean percentage with > 25% HbO2 at
each distance class, weighted by the corresponding tumour
volume associated with that distance class for each tumour.
This weighting compensates for the fact that the inner dis-
tance classes sample from smaller concentric shells of the
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Fugwe 3 Percentage of vessels with > 25% HbO2 (mean±
s.e.m.) as a function of distance from the tumour surface for
KHT i.m. implanted tumours. Untreated controls (V, 529 ± 58
mm3, n = 8) are contrasted with NIC administration (V, 530 +
65 mm3, n = 9), carbogen breathing (@, 483 ± 27 mm3, n = 7) or
the combination of both (U, 430 ± 25 mm3, n = 7).
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tumour volume than at the outer distance classes. Trends for
the KHT and SCCVII tumours generally parallel the
previous figures. For the KHT, significant overall differences
from untreated were found only for the carbogen and com-
bination treatments (P = 0.006 and 0.0008 respectively). Car-
bogen and the combination were also significantly higher
than NIC alone (P= 0.080 and 0.020). For the SCCVII,
carbogen and the combination were again significantly higher
than untreated (P=0.0003 and 0.013), NIC was different
from carbogen (P = 0.015) but not the combination (P=
0.206).
As a rule, the radiobiological hypoxic fraction (HF) of exper-
imental tumours increases with increasing tumour volume
within a given tumour line (Rofstad et al., 1988; Horsman et
al., 1995). For KHT tumours grown in the leg muscle, the
HF increased from ~-10% in 0.1-0.2g tumours to 25-35%
for 0.7-1.Og tumours (Fenton and Siemann, 1994). As the
HFs increased, the corresponding percentage with > 25%
HbO1 decreased, as expected. But this decrease in tumour
oxygen availability was not uniformly distributed over the
tumour volume. Significant changes in tumour oxygenation
were confined to blood vessels within 2 mm of the tumour
surface. For vessels closer to the centre of the tumour, HbO.
levels were quite low to begin with and were not significantly
decreased with growth.
HbO2 levels also varied substantially with implantation
site. Although the radiobiological HFs of leg- and flank-
implanted KHT tumours were similar (Fenton and Siemann,
1994), the percentage with > 25% HbO. for the leg tumours
was substantially higher. Despite essentially equal HFs for
flank or leg KHT tumours, Horsman et al. (1995) also found
2-4 times higher median p02 values for leg than for flank
tumours. This increase in oxygen availability in the leg
tumours may relate to differences in the host vasculature or
relative blood flow in the different sites, among other factors
(Young et al., 1979; Vaupel and Mueller-Klieser, 1986). Since
the leg muscle would be expected to have higher oxygen
requirements than the subcutaneous flank, it stands to reason
that leg tumours should also tend to be better vascularised
and oxygenated. It remains difficult to explain why the HbO,
or pO2 levels do not correlate with the hypoxic fractions
between the two sites, although, if the tumour cells surround-
ing the low-HbO. vessels in the flank are predominantly
non-clonogenic, the resultant oxygen profiles would be lower
in this site than in the leg without a corresponding increase
in the radiobiological hypoxic fraction (Fenton et al., 1995).
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Fige 4 Percentage of vessels with > 25% HbO, (mean +
s.e.m.) as a function of distance from the tumour surface for
SCCVII i.m. implanted tumours. Untreated controls (V, 503 ±
62 mm3, n = 8) are contrasted with NIC administration (V.
456 ±43 mm3, n = 7), carbogen breathing (0, 423 ± 30 mm3,
n = 7) or the combination of both (-, 460 ± 18mm3, n = 7).
Untreated NIC CAR Both
Treatment
Fugue 5 Overall percentage vessels with _ 25% HbO, satura-
tion (mean ± s.e.m.) as a function of treatment for KHT (-) and
SCCVII (0) tumours. 'Both' denotes the combination of NIC
and carbogen, and numbers of tumours are as described for
Figures 4 and 5.
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A number of additional mechanisms have also been sug-
gested previously (Rofstad et al., 1988).
Carbogen breathing and the combination ofcarbogen plus
NIC provided the greatest enhancement of tumour oxygen
availability for both the KHT and the SCCVII tumours, and
this enhancement was not significantly different between the
two treatments. HbO2 levels were improved for only one
distance class following NIC for either KHT or SCCVII
tumours. Although these results suggest that tumour radio-
sensitivity should also tend to be highest following the car-
bogen and combination treatments, published changes in
radioresponse following these agents do not support this
conclusion. Siemann et al. (1994) found that NIC and carbo-
gen were equally effective at radiosensitising KHT tumours.
In addition, the radiosensitivity enhancement resulting from
the combination of NIC and carbogen was equivalent to
either agent alone if delivered under optimum conditions.
These findings differ from the current results primarily in
respect of the effect of NIC administration, in that tumour
radiosensitivity is increased without a marked change in
tumour oxygenation.
For subcutaneous SCCVII tumours, Chaplin et al. (1993)
also reported that carbogen and NIC produced equivalent
improvements in radioresponse. In contrast to the KHT
tumours, however, the combination treatment produced a
greater enhancement of radiation response than either agent
alone. The radiosensitisation following either NIC or car-
bogen was essentially the same, despite markedly different
HbO2 profiles. Since the combination treatment produced the
same effect on radiosensitivity as the fully aerobic response in
the SCCVII tumours (Chaplin et al., 1993), and since the
interior of these tumours remains very poorly oxygenated
following the combination treatment, it follows that these
interior tumour cells must be non-clonogenic to begin with
and therefore irrelevant in terms of radiotherapy.
In a study using C3H mouse mammary carcinomas (Hors-
man et at., 1995), changes in the fraction of P02 readings
S 5 mmHg generally correlated with the corresponding HFs
following different oxygen manipulations. However, changes
in tumour pO2 levels following NIC and carbogen were again
inconsistent. Tumours were much better oxygenated follow-
ing carbogen than NIC, in spite of equivalent radiosen-
sitivities following either treatment. As was the case for the
HbO2 measurements, pO2 levels following NIC were not
different from the air-breathing controls. In the studies of
Martin et al. (1994), the relationship between pO2 profiles
and surviving fraction varied markedly among tumour lines.
In one, cell survival rmnained essentially constant between
NIC and carbogen treatments, in spite of substantial differ-
ences in pO2 profiles. Surprisingly, NIC increased tumour
oxygenation more than carbogen in all three lines. Additional
studies have shown similar variability between tumour lines
in the radioresponse following NIC, carbogen or the com-
bination (Kjellen et al., 1991; Simon et al., 1993; Dorie et al.,
1994).
The current disparity between HbO2 results and HF
changes can be rationalised if it is assumed that NIC and
carbogen oxygenate different subpopulations of clonogenic vs
non-clonogenic tumour cells. While direct measures of
tumour oxygenation cannot distinguish between clonogenic
and non-clonogenic cells, the radiobiological HF depends
directly on the relative fractions of anoxic and oxygenated
clonogenic cells contained in the tumour (Moulder and
Rockwell, 1984; Fenton et al., 1995). As described more fully
in a previous theoretical study (Fenton et al., 1995), HF
determinations can vary independently of directly measured
changes in tumour oxygenation within the non-clonogenic
subpopulation. Thus, if a higher proportion of non-clono-
genic vs clonogenic cells is oxygenated following a given
treatment, higher oxygen levels will be observed in relation to
the corresponding reduction in cell survival.
Carbogen breathing is believed to improve tumour oxygen-
ation primarily by increasing the diffiLsion distance of the
oxygen from the blood vessels
- thus the clonogenic anoxic
cells at the edge of the previously oxygenated regions will be
the first cells oxygenated. As the oxygen diffuses further,
anoxic cells may be reached that have been without oxygen
long enough to become non-clonogenic while remaining
viable. Increasing the diffiusion distance enough to oxygenate
these non-clonogenic cells results in an 'overkill' phenomenon
in which no further enhancement of tumour radiosensitivity
is realised in spite of the increased oxygen availability. Since
the HF decreases in conjunction with the increase in tumour
oxygenation following carbogen, an increase in oxygen
delivery to some proportion of the clonogenic anoxic cells
must also be occurring.
Previous work has suggested that NIC may act in part by
reducing intermittent fluctuations in tumour blood flow
(Chaplin et al., 1990). If this is the case, some of the tumour
cells that are oxygenated following NIC will be those that
were previously exposed to intermittent flow. It is reasonable
that such acutely hypoxic cells would more likely remain
clonogenic than cells that have been beyond the diffusion
distance of oxygen for extended periods of time (chronic
hypoxia). This implies that differences in the frequency of
intermittent blood flow between tumour lines could directly
influence the correlation between tumour oxygenation and
radioresponse for these same tumour lines. Other evidence
that NIC may act by reducing intermittent flow is provided
by Lee and Song (1992), who found that the effect of NIC
administration was greater in large tumours than in small.
They also attribute these differences to the fact that larger
tumours are more likely to have intermittently opening blood
vessels than small tumours (Chaplin et al., 1986; Trotter et
al., 1989; Lord et al., 1993).
But do such differences in intermittent flow exist between
the KHT and SCCVH tumour lines? For SCCVII tumours,
the number of blood vessels opening and closing over a
20 mm penod has been reported to be 10.3% (Chaplin et al.,
1990), based on dual-staining techniques. In the KHT
tumours, only 4% intermittently flowing vessels were
observed (Fenton and Siemann, 1994). Thus, in either case, a
reduction in intermittent flow may have a relatively minor
overall effect on tumour oxygenation. Although NIC-induced
improvements in HbO2 levels were observed only in the
peripheral vessels, Chaplin et al (1990) report that flow inter-
mittencies are, in contrast, more prevalent in central tumour
regions. However, their dual-staining techniques are only
capable of measuring whether a given blood vessel contains
active blood flow - not whether this flow is functional in
terms of oxygen delivery (Fenton and Boyce, 1993). Thus
changes in dual-staining intermittency for blood vessels con-
taining very low HbO2 levels may or may not relate to either
tumour oxygenation or radioresponse. Since overall HbO2
levels were not substantially improved following NIC for
either the KHT or the SCCVH, it appears unlikely that a
NMC-induced decrease in acute hypoxia is the predominant
mechanism for altenng radioresponse in either tumour
model. This suggests that the beneficial effects of combining
NIC and carbogen may not involve a decrease in acutely
hypoxic cells in all cases.
Finally, why are SCCVH and KHT HbO2 levels increased
so much more with carbogen than with NIC, despite similar
effects on radiosensitivity? One possibility, is that, although
both treatments may increase oxygen delivery to the clono-
genic anoxic subpopulation, the carbogen may also tend to
oxygenate some population of non-clonogenic anoxic cells.
Following NIC, radioresponse increases with a minimal in-
crease in oxygen availability, suggesting a redistribution of
oxygen from non-clonogenic oxygenated cells to clonogenic
anoxic cells. If NMC also reduces intermittent flow, then
oxygen that was previously distributed to the non-clonogenic
cells most distant from the previously open vessels will now
be diverted to the clonogenic cells surrounding the newly
opened vessels. Thus, less flow is now distributed among
more vessels. This tends to decrease the oxygen diffusion
distance while increasing oxygen delivery to the closest (and
presumably clonogenic) tumour cells.
A final possible explanation for the NIC-induced radiosen-
sitisation in the absence of significantly higher oxygen levelsCabo_ md Ndcad -aide d on bmou uygnabon
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is the possibility that NIC may act by inhibiting radiation-
induced potentially lethal damage repair. While this result
has been demonstrated in vitro, further studies have sug-
gested that repair inhibition is not the principle mechanism
responsible for in vivo tumour radiosensitisation (Horsman et
al.. 1987).
In summary, it is clear that response to carbogen and NIC
manipulation vanres substantially with tumour line in terms
of both tumour radiosensitivity and direct measures of
tumour oxygenation. The dilemma is that no currently avail-
able method exists for predicting whether or not a correlation
will exist between the two measures in a given tumour. Thus
defining an 'optimal' manipulative agent solely on the basis
of its ability to increase tumour oxygenation may lead to
erroneous conclusions. Contrary to some previous findings
(Martin et al., 1994), alterations in tumour oxygenation
within a given tumour line may not be reflective of corres-
ponding changes in tumour radiosensitivity if significantly
different fractions of non-clonogenic tumour cells are involv-
ed. Further work is needed both to describe the underlying
physiological basis for the observed discrepancies and to
discover more representative methods for estimating tumour
radioresponse following oxygen manipulation. In addition,
better methods for quantiffying intermittencies in 'functional
flow' are needed such that more subtle changes in tumour
perfusion may be recognised.
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